- EQ Investors - https://eqinvestors.co.uk -

Linden Thomson

Linden has over 12 years of experience in medical and biotechnology investing, including 5 years as an equity analyst at Goldman Sachs, before moving to the buy side where she worked as a pharmaceutical and technology analyst at the hedge fund Clear River Capital and finally to her current role at AXA. Linden is a CFA Charterholder and has a Bachelor’s degree in Medical Microbiology.